To investigate whether lactate-induced TCF-1 expressing CD8+ T cells can improve tumor therapy, we harvested and intravenously injected OVA-specific CD8+ T cells into MC38-OVA tumor bearing mice (Fig. 7a). The gene discussed is CD8A; the disease is neoplasm.